Reddy’s, Aurobindo Pharma, Zydus Lifesciences, Sun Pharma, and Gland Pharma earning up to 50% of their total revenue from the American market. Experts warn that the imposition of higher tariffs ...

Generic drugmaker Aurobindo Pharma has received final approval from the U.S. Food and Drug Administration (U.S. FDA) to manufacture and market Rivaroxaban Tablets USP, 2.5 mg. The approved ...

An inhalers and derma products manufacturing plant of Aurobindo Pharma subsidiary Aurolife Pharma LLC in the U.S. has been issued 11 observations by the United States Food and Drug Administration.

Hyderabad: Aurobindo Pharma has announced that the United States Food and Drug Administration (USFDA) has issued 11 observations after an inspection at Raleigh Plant, North Carolina, USA, owned by ...

Aurobindo Pharma Ltd. announced on Friday that its subsidiary, Aurolife Pharma LLC, has received a Form 483 with 11 observations from the US Food and Drug Administration following an inspection of its ...

Aurobindo Pharma Ltd received a Form 483 from the USFDA with 11 procedural observations for its Raleigh plant managed by Aurolife Pharma LLC. The inspection occurred from March 24 to April 10, 2025.

Aurobindo Pharma shares jumped 5 per cent on Friday, April 11, 2025, logging an intraday high at ₹1,110 per share on BSE. The stock rallied after the company's subsidiary, CuraTeQ Biologics, completed ...

Aurobindo Pharma received a Form 483 with 11 observations from the USFDA for its Raleigh plant in North Carolina. The company plans to address the procedural observations. New Delhi, Apr 11 (PTI) ...

Aurobindo Pharma announced that its subsidiary CuraTeQ Biologics has received successful trial results for its new bone treatment medicine. The drug, called BP16, is a biosimilar of an existing ...

The US Food and Drug Administration (USFDA) had conducted inspection at the plant from March 24, 2025, to April 10, 2025, Aurobindo Pharma said in a regulatory filing.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Pharma stocks such as Sun Pharma, Aurobindo Pharma, Dr Reddy's Lab, Cipla, Gland Pharma, Zydus Lifesciences and Lupin would be in action on Friday after the US President Donald Trump halted ...